Tools

LEADER 02678nam 2200529 i 4500

001 on1473301542;

003 OCoLC;

005 20250120152056.0;

006 m o d f ;

007 cr |||||||||||;

008 241125s2024 dcua ob f000 0 eng c;

035 a| (Sirsi) o1473301542;

042 a| pcc;

043 a| n-us---;

049 a| ERE#;

074 a| 0546-D (online);

086 0 a| GA 1.13:GAO-25-106774;

088 a| GAO-25-106774;

245 10 a| Rare disease drugs :b| FDA has steps underway to strengthen coordination of activities supporting drug development : report to congressional committees /c| United States Government Accountability Office.;

246 3 a| Rare disease drugs :b| Food and Drug Administration has steps underway to strengthen coordination of activities supporting drug development;

246 30 a| FDA has steps underway to strengthen coordination of activities supporting drug development;

246 17 a| GAO-25-106774 Rare disease drugs;

264 1 a| Washington, DC :b| United States Government Accountability Office,c| 2024.;

300 a| 1 online resource (iii, 57 pages) :b| color illustrations;

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

500 a| "November 2024.";

500 a| "GAO-25-106774.";

500 a| In scope of the U.S. Government Publishing Office Catalog and Indexing Program (C&I) and Federal Depository Library Program (FDLP).;

500 a| GPO Cataloging Record Distribution Program (CRDP).;

504 a| Includes bibliographical references.;

588 a| Description based on online resource; title from PDF title page (GAO, viewed November 25, 2024).;

610 10 a| United States.b| Food and Drug Administrationv| Rules and practice.=| ^A1253;

610 20 a| Center for Drug Evaluation and Research (U.S.)0| https://id.loc.gov/authorities/names/n88077221=| ^A431016;

610 20 a| Center for Biologics Evaluation and Research (U.S.)0| https://id.loc.gov/authorities/names/n88098944=| ^A368272;

650 0 a| Drug developmentz| United States.=| ^A443888;

650 0 a| Orphan drugsz| United States.=| ^A425649;

650 0 a| Rare diseasesz| United States.=| ^A856309;

856 40 u| https://purl.fdlp.gov/GPO/gpo2347657| 0;

922 a| BIBCONEWb| 20241125;

949 a| Click on web addressw| asish| joyner94;

596 a| 1;

998 a| 6501000;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 6501000-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 12/13/2024x| EDOCUMENTz| JERESOURCE;

Rare disease drugs : FDA has steps underway to strengthen coordination of activities supporting drug development : report to congressional committees / United States Government Accountability Office.

Author/creator	United States
Format	Electronic
Publication	Washington, DC : United States Government Accountability Office, 2024.
Description	1 online resource (iii, 57 pages) : color illustrations
Supplemental Content	https://purl.fdlp.gov/GPO/gpo234765
Subjects	United States. Food and Drug Administration--Rules and practice. Center for Drug Evaluation and Research (U.S.) Center for Biologics Evaluation and Research (U.S.) Drug development--United States. Orphan drugs--United States. Rare diseases--United States.

Variant title	Rare disease drugs : Food and Drug Administration has steps underway to strengthen coordination of activities supporting drug development
Portion of title	FDA has steps underway to strengthen coordination of activities supporting drug development
Running title	GAO-25-106774 Rare disease drugs
General note	"November 2024."
General note	"GAO-25-106774."
General note	In scope of the U.S. Government Publishing Office Catalog and Indexing Program (C&I) and Federal Depository Library Program (FDLP).
General note	GPO Cataloging Record Distribution Program (CRDP).
Bibliography note	Includes bibliographical references.
Source of description	Description based on online resource; title from PDF title page (GAO, viewed November 25, 2024).
Technical rpt number	GAO-25-106774
GPO item number	0546-D (online)
Govt. docs number	GA 1.13:GAO-25-106774

Rare disease drugs : FDA has steps underway to strengthen coordination of activities supporting drug development : report to congressional committees / United States Government Accountability Office.

Click here for more information about this title